BIOMEDICAL DATA SOLUTIONS LIMITED
Get an alert when BIOMEDICAL DATA SOLUTIONS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-18 (in 4mo)
Last made up 2025-09-04
Watchouts
None on the register
Accounts
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As at the balance sheet date, the company has net assets of £4,160,723 and cash of £1,385,380. The Directors have prepared a going concern assessment based upon post year end and forecast trading for the company. The directors have performed sensitivity analysis on these forecasts and concluded the company is able to meet its obligations as they fall due, for at least 12 months from signing these financial statements. The company has done modelling of revenues by project, including levels of new customer acquisition, recurring subscription revenue and churn rates. Detailed modelling has been performed on the level of costs and investments required, taking account of inflation and other macroeconomic trends. The conversion of trading into cash was also modelled, taking account of project timings, liability repayments and potential taxation liabilities. On this basis, the directors are satisfied it is appropriate to prepare these financial statements on a going concern basis.”
Group structure
- BIOMEDICAL DATA SOLUTIONS LIMITED · parent
- Sanguin International Inc. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSON, Ryan | Director | 2025-02-11 | May 1995 | British |
| STEAD, Rebecca | Director | 2019-04-01 | Oct 1979 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEXTER, Mark | Secretary | 2012-02-13 | 2015-10-13 |
| DUCKWORTH, Anthony John | Secretary | — | 1999-08-31 |
| GREENWOOD-PHILLIPS, Benjamin | Secretary | 2025-02-11 | 2026-03-04 |
| WHELAN, Richard | Secretary | 1999-08-31 | 2012-02-13 |
| BAKKER, Pascal Denijs | Director | 2024-09-09 | 2025-02-11 |
| DEXTER, Mark | Director | 2011-11-01 | 2015-10-13 |
| DUCKWORTH, Anthony John | Director | — | 2001-02-01 |
| HIGGS, Connie | Director | 2015-11-01 | 2020-04-30 |
| HILL, Ian | Director | 2015-11-01 | 2018-10-31 |
| KUENZEL, Andreas | Director | 2014-07-01 | 2020-04-30 |
| PIEK, Jurriaan Leonard Jan Frederik | Director | 2020-05-04 | 2024-09-09 |
| PITTS, Elaine | Director | 1995-09-01 | 2014-07-31 |
| ROBERTS, Philip Richard | Director | 2011-03-15 | 2011-10-31 |
| SIEGLE, Robert, Dr | Director | 2011-03-15 | 2014-07-04 |
| VALE, David Roger | Director | — | 2007-10-31 |
| WHELAN, Richard | Director | — | 2012-05-25 |
| WOLFINGER, Markus Karl | Director | 2006-03-10 | 2011-03-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Stratec Biomedical Ag | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, Significant influence | 2016-04-06 | Ceased 2020-05-04 |
Filing timeline
Last 20 of 143 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-12 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-09-19 | AA | accounts | Accounts with accounts type full | |
| 2025-09-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-12 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-02-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-08 | AA | accounts | Accounts with accounts type full | |
| 2024-09-22 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-22 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-22 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-18 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-09 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-11-08 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-10-30 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-09-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-05 | AA | accounts | Accounts with accounts type full | |
| 2022-09-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-15 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one